Chidambaram Rammohan, MD
Interventional Cardiology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 10
Offices
10 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Hospitals listed: California Pacific Medical Center- Van Ness Campus · El Camino Health · Sequoia Hospital. That is not proof they admit you there this week.
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Rammohan’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A71128 · Current
Licensed to practise in California · since 2000 · expires 2028-02-29 · Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Sequoia HospitalRedwood City, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 104.12 (51.8 to 156.44) · 56 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Sequoia Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 104.12 (51.8 to 156.44) · 56 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.98) · 472 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.58 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.1 · 258 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.5 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,231 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 3,018 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.44) · 3,164 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.59 (0.47 to 4.71) · 1,402 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.47 (0.04 to 2.9) · 926 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.68 (0.21 to 3.16) · 1,310 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.54 (4.42 to 14.67) · 978 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.61 to 8.36) · 924 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.69 (0.19 to 3.19) · 192 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.57 (0 to 1.43) · 2,501 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 332 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.702 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.853 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 67 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 295 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -27.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.3 · 304 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.6 · 178 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 180 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 305 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 29 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.7 to 17.7) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 713 cases | No different | Jan 2024 – Dec 2024 |
What patients said (631 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 81% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$443,926
Medicare paid this office $443,926 for 1,254 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of aortic valve through the skin and femoral artery | 96 | $60,204 | $621 |
| Repair of left upper heart chamber with implant with review by radiologist | 77 | $44,833 | $582 |
| Repair of mitral valve through the skin, initial prosthesis | 28 | $42,077 | $1,503 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 196 | $39,315 | $192 |
| Return visit (30+ min) | 273 | $37,420 | $112 |
See all 31 services
| Replacement of aortic valve through the skin and femoral artery | 96 | $60,204 | $621 |
| Repair of left upper heart chamber with implant with review by radiologist | 77 | $44,833 | $582 |
| Repair of mitral valve through the skin, initial prosthesis | 28 | $42,077 | $1,503 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 196 | $39,315 | $192 |
| Return visit (30+ min) | 273 | $37,420 | $112 |
| New patient visit (60+ min) | 166 | $33,669 | $203 |
| Long return visit (40+ min) | 130 | $24,309 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $14,815 | $107 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 203 | $13,092 | $60 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 28 | $12,103 | $356 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 66 | $10,887 | $156 |
| Hospital discharge day management, more than 30 minutes | 92 | $9,542 | $104 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 44 | $8,701 | $198 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 30 | $6,952 | $232 |
| Insertion of permanent leadless pacemaker using imaging guidance | 15 | $5,918 | $395 |
| Critical care, first 30-74 minutes | 18 | $5,514 | $178 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 405 | $5,374 | $13 |
| Repair of mitral valve through the skin, additional prosthesis | 15 | $5,208 | $347 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 39 | $4,781 | $117 |
| Short return visit (20+ min) | 51 | $4,619 | $84 |
| Programming of dual lead pacemaker system | 30 | $3,155 | $73 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 39 | $1,904 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 45 | $1,902 | $22 |
| Ultrasound of heart, follow-up | 71 | $1,647 | $22 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 83 | $1,277 | $15 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 15 | $1,264 | $79 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 74 | $800 | $11 |
| Ultrasonic guidance for blood vessel access | 49 | $599 | $12 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 17 | $396 | $21 |
| Heart rhythm recording of continous external ekg over 8-15 days | 17 | $239 | $13 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 32 | $202 | $6 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 47 | More than 80% of doctors who do this |
| Pacemaker insertion or repair | 31 | More than 79% of doctors who do this |
Who their Medicare patients are
1,254 Original Medicare patients in 2024. Average age 79 · Under 65 2% · 85 and older 26% · Women 47% · Also on Medicaid 12% · Health risk score 1.45. At or below the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 48% · Atrial fibrillation 41% · Chronic kidney disease 31% · Heart failure 30% · Diabetes 29% · Cancer 22% · Depression 17% · COPD 12% · Stroke 11% · Dementia 10%.
The office billed $2,056,047, Medicare allowed $570,561 and paid $443,926; for 3,016 services of 90 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,254 | 3,016 | 79 | 1.45 | $2,056,047 | $443,926 |
| 2023 | 1,225 | 2,822 | 79 | 1.37 | $1,904,801 | $426,531 |
| 2022 | 1,362 | 2,763 | 79 | 1.31 | $1,789,162 | $416,412 |
| 2021 | 1,515 | 3,232 | 78 | 1.48 | $1,867,660 | $485,384 |
| 2020 | 1,515 | 3,247 | 78 | 1.54 | $1,622,634 | $410,291 |
| 2019 | 1,649 | 3,244 | 78 | 1.38 | $1,606,052 | $401,961 |
| 2018 | 1,796 | 3,333 | 77 | 1.43 | $1,467,787 | $373,791 |
| 2017 | 1,710 | 3,198 | 76 | 1.37 | $1,424,845 | $354,918 |
| 2016 | 1,701 | 3,197 | 77 | 1.43 | $1,349,078 | $352,635 |
| 2015 | 1,713 | 3,482 | 77 | 1.36 | $1,361,795 | $373,067 |
| 2014 | 1,402 | 3,092 | 77 | 1.21 | $1,437,958 | $343,376 |
| 2013 | 1,467 | 2,888 | 77 | 1.45 | $1,217,184 | $280,574 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 29 services
| Replacement of aortic valve through the skin and femoral artery | 92 | $58,605 | $637 |
| Repair of mitral valve through the skin, initial prosthesis | 31 | $47,677 | $1,538 |
| Return visit (30+ min) | 284 | $42,258 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 178 | $36,804 | $193 |
| New patient visit (60+ min) | 158 | $32,176 | $204 |
| Repair of left upper heart chamber with implant with review by radiologist | 44 | $23,286 | $529 |
| Long return visit (40+ min) | 111 | $20,682 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $16,938 | $109 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 216 | $14,109 | $61 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 67 | $13,630 | $200 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 26 | $13,218 | $413 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $12,463 | $158 |
| Critical care, first 30-74 minutes | 23 | $9,836 | $189 |
| Insertion of permanent leadless pacemaker using imaging guidance | 21 | $8,343 | $397 |
| Hospital discharge day management, more than 30 minutes | 73 | $7,853 | $106 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 31 | $7,200 | $232 |
| Repair of mitral valve through the skin, additional prosthesis | 15 | $5,379 | $359 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 390 | $5,273 | $13 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 39 | $5,039 | $120 |
| Programming of dual lead pacemaker system | 32 | $3,817 | $75 |
| Short return visit (20+ min) | 36 | $2,695 | $71 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 31 | $914 | $22 |
| Ultrasound of heart, follow-up | 37 | $849 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 28 | $799 | $25 |
| Ultrasonic guidance for blood vessel access | 36 | $487 | $12 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 21 | $455 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 27 | $297 | $11 |
| Heart rhythm recording of continous external ekg over 8-15 days | 21 | $257 | $12 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 18 | $117 | $7 |
2022: 29 services
| Replacement of aortic valve through the skin and femoral artery | 90 | $59,072 | $649 |
| Repair of mitral valve through the skin, initial prosthesis | 31 | $50,284 | $1,571 |
| Return visit (30+ min) | 300 | $41,789 | $108 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 185 | $39,227 | $202 |
| New patient visit (60+ min) | 172 | $35,349 | $206 |
| Repair of left upper heart chamber with implant with review by radiologist | 54 | $27,411 | $508 |
| Long return visit (40+ min) | 100 | $17,975 | $166 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $12,034 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 183 | $11,983 | $63 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $10,951 | $421 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $9,802 | $182 |
| Hospital discharge day management, more than 30 minutes | 88 | $8,347 | $94 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 530 | $7,219 | $13 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 33 | $6,583 | $199 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 30 | $6,444 | $215 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 44 | $6,382 | $145 |
| Insertion of permanent leadless pacemaker using imaging guidance | 15 | $5,899 | $393 |
| Repair of mitral valve through the skin, additional prosthesis | 15 | $5,491 | $366 |
| Short return visit (20+ min) | 53 | $5,029 | $81 |
| Critical care, first 30-74 minutes | 12 | $2,953 | $197 |
| Programming of dual lead pacemaker system | 29 | $2,894 | $71 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 37 | $1,155 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 31 | $895 | $22 |
| Ultrasound of heart, follow-up | 34 | $808 | $22 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 24 | $564 | $22 |
| Heart rhythm recording of continous external ekg over 8-15 days | 24 | $361 | $14 |
| Ultrasonic guidance for blood vessel access | 20 | $261 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 13 | $145 | $11 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 16 | $105 | $7 |
2021: 32 services
| Repair of mitral valve through the skin, initial prosthesis | 48 | $75,344 | $1,570 |
| Replacement of aortic valve through the skin and femoral artery | 104 | $68,333 | $657 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 193 | $41,150 | $202 |
| Return visit (30+ min) | 268 | $39,160 | $116 |
| New patient visit (60+ min) | 159 | $33,795 | $213 |
| Long return visit (40+ min) | 122 | $22,193 | $171 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 30 | $17,232 | $392 |
| Repair of left upper heart chamber with implant with review by radiologist | 37 | $16,094 | $435 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 66 | $15,708 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 219 | $15,537 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 79 | $15,074 | $184 |
| Hospital discharge day management, more than 30 minutes | 124 | $13,053 | $100 |
| Repair of mitral valve through the skin, additional prosthesis | 32 | $11,713 | $366 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 35 | $8,235 | $235 |
| Short return visit (20+ min) | 94 | $7,847 | $75 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 547 | $7,722 | $14 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 39 | $7,556 | $189 |
| Insertion of permanent leadless pacemaker using imaging guidance | 16 | $6,649 | $416 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $6,173 | $475 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 47 | $6,030 | $128 |
| Critical care, first 30-74 minutes | 14 | $3,379 | $199 |
| Programming of dual lead pacemaker system | 38 | $3,175 | $66 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 45 | $1,351 | $21 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 140 | $1,268 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 36 | $1,065 | $23 |
| Programming of single lead pacemaker system | 12 | $718 | $51 |
| Ultrasound of heart, follow-up | 28 | $707 | $24 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 25 | $584 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 25 | $393 | $16 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $246 | $22 |
| Ultrasonic guidance for blood vessel access | 19 | $239 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 20 | $229 | $11 |
2020: 34 services
| Repair of mitral valve through the skin, initial prosthesis | 36 | $58,308 | $1,620 |
| Replacement of aortic valve through the skin and femoral artery | 81 | $54,512 | $673 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 231 | $51,023 | $208 |
| Return visit (30+ min) | 241 | $27,782 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 82 | $18,532 | $97 |
| New patient visit (60+ min) | 83 | $15,940 | $192 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $15,517 | $185 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 190 | $13,672 | $68 |
| Long return visit (40+ min) | 87 | $12,997 | $137 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 22 | $11,813 | $454 |
| Short return visit (20+ min) | 151 | $10,410 | $65 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 43 | $9,775 | $227 |
| Hospital discharge day management, more than 30 minutes | 87 | $8,753 | $101 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 500 | $7,833 | $15 |
| Insertion of permanent leadless pacemaker using imaging guidance | 19 | $7,604 | $400 |
| Repair of mitral valve through the skin, additional prosthesis | 19 | $7,226 | $380 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 34 | $6,759 | $199 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 15 | $6,675 | $445 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 17 | $5,527 | $325 |
| Repair of left upper heart chamber with implant with review by radiologist | 12 | $5,297 | $441 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 39 | $4,759 | $119 |
| Programming of dual lead pacemaker system | 43 | $3,647 | $64 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 283 | $2,515 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 46 | $1,566 | $24 |
| Telephone medical discussion with physician, 11-20 minutes | 23 | $1,398 | $61 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 36 | $1,143 | $25 |
| External ekg recording for more than 48 hours up to 21 days | 42 | $1,083 | $26 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 42 | $964 | $23 |
| Programming of single lead pacemaker system | 11 | $930 | $52 |
| Short return visit | 22 | $890 | $40 |
| Ultrasound of heart, follow-up | 29 | $705 | $24 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $543 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 23 | $273 | $11 |
| Ultrasonic guidance for blood vessel access | 17 | $226 | $13 |
2019: 29 services
| Repair of mitral valve through the skin, initial prosthesis | 38 | $59,569 | $1,568 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 232 | $50,775 | $205 |
| Replacement of aortic valve through the skin and femoral artery | 61 | $45,000 | $738 |
| Return visit (30+ min) | 332 | $40,953 | $94 |
| New patient visit (60+ min) | 105 | $19,719 | $188 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 58 | $13,081 | $222 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 27 | $12,801 | $427 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 155 | $11,085 | $66 |
| Long return visit (40+ min) | 75 | $10,934 | $133 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $10,916 | $93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 664 | $10,498 | $15 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 48 | $9,858 | $205 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 22 | $9,854 | $448 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $9,381 | $184 |
| Repair of mitral valve through the skin, additional prosthesis | 20 | $7,424 | $371 |
| Hospital discharge day management, more than 30 minutes | 79 | $7,366 | $92 |
| Repair of left upper heart chamber with implant with review by radiologist | 15 | $6,809 | $454 |
| Short return visit (20+ min) | 69 | $4,892 | $66 |
| Programming of dual lead pacemaker system | 47 | $4,337 | $58 |
| Critical care, first 30-74 minutes | 12 | $4,175 | $199 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 28 | $4,043 | $135 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 268 | $2,470 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 22 | $750 | $25 |
| Ultrasound of heart, follow-up | 29 | $737 | $24 |
| External ekg recording for more than 48 hours up to 21 days | 23 | $620 | $25 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 50 | $579 | $11 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 23 | $542 | $22 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 15 | $422 | $26 |
| Ultrasonic guidance for blood vessel access | 25 | $340 | $13 |
2018: 31 services
| Repair of mitral valve through the skin, initial prosthesis | 35 | $52,096 | $1,447 |
| Return visit (30+ min) | 422 | $49,737 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 214 | $47,314 | $204 |
| Replacement of aortic valve through the skin and femoral artery | 44 | $31,849 | $724 |
| Long return visit (40+ min) | 108 | $16,298 | $133 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 63 | $14,169 | $225 |
| New patient visit (60+ min) | 75 | $13,993 | $187 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $12,106 | $417 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $11,347 | $92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 678 | $10,216 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 146 | $9,967 | $62 |
| Repair of left upper heart chamber with implant with review by radiologist | 17 | $9,326 | $518 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $8,400 | $179 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 22 | $6,845 | $311 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 31 | $5,724 | $179 |
| Hospital discharge day management, more than 30 minutes | 62 | $5,678 | $92 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $5,522 | $425 |
| Repair of mitral valve through the skin, additional prosthesis | 17 | $5,501 | $324 |
| Programming of dual lead pacemaker system | 53 | $3,883 | $49 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 334 | $2,648 | $7 |
| Critical care, first 30-74 minutes | 12 | $2,548 | $196 |
| Short return visit (20+ min) | 36 | $2,243 | $61 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 14 | $1,769 | $126 |
| External ekg recording for more than 48 hours up to 21 days | 23 | $596 | $25 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 15 | $596 | $27 |
| Ultrasound of heart, follow-up | 18 | $536 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 45 | $518 | $11 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 23 | $515 | $21 |
| Electrocardiogram (ecg) 2-day continuous | 14 | $348 | $25 |
| Ultrasonic guidance for blood vessel access | 25 | $321 | $13 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 14 | $319 | $23 |
2017: 31 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 226 | $52,053 | $218 |
| Return visit (30+ min) | 377 | $49,176 | $90 |
| Repair of mitral valve through the skin, initial prosthesis | 27 | $42,918 | $1,533 |
| Replacement of aortic valve through the skin and femoral artery | 28 | $20,920 | $721 |
| Long return visit (40+ min) | 118 | $17,015 | $124 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 55 | $14,635 | $266 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 27 | $13,417 | $419 |
| New patient visit (60+ min) | 68 | $12,779 | $188 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $11,484 | $93 |
| Repair of left upper heart chamber with implant with review by radiologist | 19 | $10,526 | $554 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $10,515 | $181 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 675 | $10,276 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 144 | $8,509 | $55 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 34 | $7,329 | $198 |
| Hospital discharge day management, more than 30 minutes | 54 | $5,249 | $91 |
| Critical care, first 30-74 minutes | 17 | $5,103 | $196 |
| Repair of mitral valve through the skin, additional prosthesis | 13 | $4,745 | $365 |
| Programming of dual lead pacemaker system | 52 | $4,053 | $51 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 11 | $2,927 | $266 |
| New patient visit (45+ min) | 20 | $2,701 | $135 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 251 | $2,449 | $7 |
| Short return visit (20+ min) | 36 | $2,234 | $57 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 12 | $1,669 | $139 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 21 | $1,407 | $64 |
| External ekg recording for more than 48 hours up to 21 days | 18 | $487 | $27 |
| Ultrasonic guidance for blood vessel access | 33 | $448 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 35 | $404 | $11 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 17 | $398 | $23 |
| Ultrasound of heart, follow-up | 15 | $349 | $23 |
| Electrocardiogram (ecg) 2-day continuous | 13 | $332 | $26 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 13 | $294 | $23 |
2016: 29 services
| Return visit (30+ min) | 371 | $49,965 | $92 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 215 | $49,679 | $223 |
| Replacement of aortic valve through the skin and femoral artery | 38 | $27,470 | $723 |
| Radiological supervision and interpretation of catheter-delivered implant (accessed through the skin) to left upper heart chamber for appendage closure | 15 | $24,786 | $1,652 |
| Repair of mitral valve through the skin, initial prosthesis | 17 | $23,999 | $1,412 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | $13,443 | $464 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 58 | $12,455 | $92 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 41 | $10,565 | $258 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $10,535 | $173 |
| Long return visit (40+ min) | 79 | $10,515 | $128 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 630 | $9,665 | $15 |
| Short return visit (20+ min) | 130 | $8,583 | $55 |
| New patient visit (60+ min) | 48 | $8,562 | $178 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 134 | $7,540 | $54 |
| Hospital discharge day management, more than 30 minutes | 70 | $6,783 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $6,401 | $60 |
| New patient visit (45+ min) | 39 | $5,499 | $141 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 22 | $5,097 | $232 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $4,909 | $446 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 25 | $4,593 | $170 |
| Programming of dual lead pacemaker system | 50 | $4,425 | $50 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $4,208 | $324 |
| Critical care, first 30-74 minutes | 13 | $2,935 | $196 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 278 | $2,368 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 28 | $1,947 | $70 |
| Programming of single lead pacemaker system | 11 | $774 | $41 |
| Electrocardiogram (ecg) 2-day continuous | 14 | $379 | $25 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 14 | $337 | $22 |
| Ultrasonic guidance for blood vessel access | 22 | $294 | $13 |
2015: 32 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 201 | $50,735 | $233 |
| Return visit (30+ min) | 271 | $39,817 | $95 |
| Repair of mitral valve through the skin, initial prosthesis | 21 | $31,295 | $1,490 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 39 | $20,532 | $526 |
| Short return visit (20+ min) | 230 | $18,209 | $62 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $14,890 | $414 |
| Replacement of aortic valve through the skin and femoral artery | 19 | $14,500 | $763 |
| New patient visit (60+ min) | 70 | $13,090 | $187 |
| Long return visit (40+ min) | 80 | $11,794 | $140 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $11,085 | $185 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 38 | $10,411 | $274 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 623 | $10,240 | $16 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $10,238 | $98 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 38 | $10,037 | $132 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 33 | $7,687 | $226 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 123 | $7,610 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $7,269 | $68 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $5,919 | $455 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 16 | $5,285 | $330 |
| Injection, regadenoson, 0.1 mg | 31 | $5,133 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 64 | $4,528 | $71 |
| Programming of dual lead pacemaker system | 53 | $4,258 | $49 |
| Hospital discharge day management, more than 30 minutes | 36 | $3,998 | $103 |
| New patient visit (45+ min) | 19 | $2,938 | $155 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 294 | $2,723 | $8 |
| New patient visit (30+ min) | 14 | $1,260 | $90 |
| Electrocardiogram (ecg) 2-day continuous | 33 | $1,047 | $30 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 33 | $898 | $26 |
| Programming of single lead pacemaker system | 13 | $787 | $41 |
| Ultrasonic guidance for blood vessel access | 32 | $447 | $14 |
| External ekg recording for more than 48 hours up to 21 days | 11 | $326 | $30 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 11 | $279 | $25 |
2014: 30 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 196 | $47,889 | $225 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 55 | $26,875 | $489 |
| Return visit (30+ min) | 196 | $25,009 | $91 |
| Short return visit (20+ min) | 245 | $18,458 | $59 |
| New patient visit (60+ min) | 94 | $17,093 | $182 |
| Long return visit (40+ min) | 100 | $15,019 | $128 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $14,661 | $177 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 27 | $14,586 | $442 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 55 | $14,501 | $132 |
| Catheter based repair of heart valve (mitral) between left upper and lower chambers, accessed through the skin | 11 | $13,158 | $1,196 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 36 | $10,059 | $279 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 555 | $8,291 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 132 | $7,847 | $57 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 17 | $7,747 | $456 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 59 | $7,704 | $63 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 37 | $7,113 | $192 |
| Critical care, first 30-74 minutes | 20 | $5,944 | $192 |
| Injection, regadenoson, 0.1 mg | 35 | $5,690 | None |
| External ekg recording for more than 48 hours up to 21 days with analysis, report, review and interpretation | 22 | $5,674 | $247 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 82 | $5,322 | $65 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $5,266 | $92 |
| New patient visit (45+ min) | 33 | $4,588 | $139 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $4,405 | $339 |
| Programming of dual lead pacemaker system | 47 | $3,529 | $45 |
| Hospital discharge day management, more than 30 minutes | 34 | $3,266 | $93 |
| Insertion of tube in right and left heart chambers for diagnosis with review by radiologist | 15 | $2,448 | $163 |
| Insertion of tube in left heart chamber through heart septum | 11 | $1,976 | $180 |
| Electrocardiogram (ecg) 2-day continuous | 42 | $1,099 | $26 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 42 | $970 | $23 |
| Ultrasonic guidance for blood vessel access | 48 | $651 | $13 |
2013: 32 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 159 | $29,606 | $179 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 56 | $27,938 | $499 |
| Short return visit (20+ min) | 261 | $22,319 | $60 |
| Long return visit (40+ min) | 109 | $15,368 | $122 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 57 | $15,010 | $132 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $13,041 | $408 |
| Return visit (30+ min) | 95 | $12,108 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $10,014 | $176 |
| New patient visit (60+ min) | 54 | $9,569 | $177 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 16 | $9,209 | $542 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $8,551 | $450 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 495 | $8,342 | $16 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 33 | $7,588 | $230 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 112 | $6,502 | $54 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 36 | $5,943 | $89 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 82 | $5,655 | $68 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 27 | $5,047 | $180 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 15 | $4,632 | $309 |
| Injection, regadenoson, 0.1 mg | 20 | $3,365 | None |
| Programming of dual lead pacemaker system | 45 | $3,326 | $46 |
| Critical care, first 30-74 minutes | 12 | $3,250 | $191 |
| Insertion of tube in right and left heart chambers for diagnosis with review by radiologist | 14 | $3,242 | $232 |
| Insertion of tube in left heart chamber through heart septum | 17 | $2,910 | $171 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 260 | $2,382 | $7 |
| Hospital discharge day management, more than 30 minutes | 26 | $2,358 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,238 | $62 |
| New patient visit (45+ min) | 14 | $2,113 | $151 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $1,184 | $85 |
| Electrocardiogram (ecg) 2-day continuous | 31 | $876 | $28 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 31 | $700 | $23 |
| Short return visit | 13 | $609 | $38 |
| Ultrasonic guidance for blood vessel access | 13 | $164 | $13 |
Medicaid work
$404 in 2024
Medicaid paid $404 for 28 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 28 | $404 |
| 2024 | 28 | 1 | 16 | $404 |
| 2023 | 45 | 1 | 16 | $646 |
| 2022 | 17 | 1 | 17 | $285 |
| 2021 | 144 | 3 | 77 | $1,763 |
| 2020 | 184 | 2 | 61 | $1,694 |
| 2019 | 148 | 2 | 50 | $1,674 |
| 2018 | 221 | 2 | 70 | $2,248 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 45 | $646 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 17 | $285 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 14 | $914 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 40 | $461 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 90 | $388 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 145 | $851 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 39 | $842 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 60 | $1,245 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 88 | $428 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 77 | $1,461 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 144 | $786 |
Drugs they prescribed that Part D paid
$451,437
Pharmacies billed $451,437 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,133) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
1,804 generic and 329 brand-name prescriptions · $451,437 in drug cost · 18 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 221 | $289,298 | $1,309 |
| Entresto | 29 | $40,195 | $1,386 |
| Jardiance | 22 | $36,775 | $1,672 |
| Repatha Sureclick | 15 | $23,523 | $1,568 |
| Xarelto | 13 | $12,726 | $979 |
See all 31 drugs
| Eliquis | 221 | $289,298 | $1,309 |
| Entresto | 29 | $40,195 | $1,386 |
| Jardiance | 22 | $36,775 | $1,672 |
| Repatha Sureclick | 15 | $23,523 | $1,568 |
| Xarelto | 13 | $12,726 | $979 |
| Eplerenone | 16 | $3,687 | $230 |
| Metoprolol | 221 | $3,614 | $16 |
| Rosuvastatin | 204 | $2,399 | $12 |
| Atorvastatin | 209 | $1,908 | $9 |
| Valsartan | 42 | $1,656 | $39 |
| Losartan | 91 | $1,589 | $17 |
| Clopidogrel | 98 | $1,435 | $15 |
| Ezetimibe | 48 | $1,164 | $24 |
| Spironolactone | 91 | $1,080 | $12 |
| Amlodipine Besylate | 137 | $1,021 | $7 |
| Torsemide | 36 | $852 | $24 |
| Carvedilol | 84 | $828 | $10 |
| Amiodarone | 20 | $810 | $41 |
| Digoxin | 16 | $742 | $46 |
| Diltiazem 24hr Er (Cd) | 18 | $567 | $32 |
| Lisinopril | 56 | $553 | $10 |
| Metoprolol | 45 | $513 | $11 |
| Furosemide | 59 | $459 | $8 |
| Chlorthalidone | 19 | $411 | $22 |
| Enalapril Maleate | 14 | $390 | $28 |
| Sotalol Af | 13 | $297 | $23 |
| Simvastatin | 30 | $287 | $10 |
| Doxazosin Mesylate | 13 | $230 | $18 |
| Isosorbide Mononitrate Er | 12 | $200 | $17 |
| Benazepril | 12 | $46 | $4 |
| Atenolol | 15 | $46 | $3 |
Year by year
| 2024 | 2,133 | 354 | 0% (0) | 15% | $451,437 |
| 2023 | 2,292 | 362 | 0% (0) | 14% | $457,776 |
| 2022 | 2,426 | 381 | 0% (0) | 14% | $461,684 |
| 2021 | 2,559 | 389 | 0% (0) | 15% | $440,429 |
| 2020 | 2,747 | 391 | 0% (0) | 15% | $391,025 |
| 2019 | 2,743 | 397 | 0% (0) | 14% | $321,348 |
| 2018 | 3,282 | 426 | None | 13% | $314,116 |
| 2017 | 3,336 | 404 | 0% (0) | 16% | $252,190 |
| 2016 | 3,340 | 400 | 0% (0) | 17% | $197,153 |
| 2015 | 3,289 | 386 | None | 18% | $145,206 |
| 2014 | 3,439 | 383 | None | 17% | $132,665 |
| 2013 | 3,128 | 346 | None | None | $112,333 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 36 drugs
| Eliquis | 212 | $285,334 | $1,346 |
| Entresto | 35 | $38,655 | $1,104 |
| Jardiance | 17 | $29,921 | $1,760 |
| Xarelto | 12 | $21,341 | $1,778 |
| Repatha Sureclick | 13 | $18,181 | $1,399 |
| Metoprolol | 238 | $4,920 | $21 |
| Rosuvastatin | 192 | $4,497 | $23 |
| Eplerenone | 24 | $4,448 | $185 |
| Atorvastatin | 221 | $2,281 | $10 |
| Diltiazem 24hr Er (Cd) | 39 | $2,219 | $57 |
| Clopidogrel | 105 | $1,887 | $18 |
| Valsartan | 52 | $1,635 | $31 |
| Losartan | 100 | $1,431 | $14 |
| Amlodipine Besylate | 126 | $1,394 | $11 |
| Ezetimibe | 43 | $1,387 | $32 |
| Torsemide | 63 | $1,349 | $21 |
| Enalapril Maleate | 21 | $1,338 | $64 |
| Digoxin | 25 | $1,169 | $47 |
| Spironolactone | 91 | $1,072 | $12 |
| Carvedilol | 80 | $754 | $9 |
| Metoprolol | 59 | $700 | $12 |
| Flecainide Acetate | 13 | $582 | $45 |
| Bisoprolol | 13 | $572 | $44 |
| Furosemide | 60 | $512 | $9 |
| Chlorthalidone | 26 | $459 | $18 |
| Lisinopril | 67 | $447 | $7 |
| Amiodarone | 12 | $428 | $36 |
| Nitroglycerin | 13 | $384 | $30 |
| Simvastatin | 31 | $375 | $12 |
| Isosorbide Mononitrate Er | 14 | $372 | $27 |
| Pravastatin | 12 | $275 | $23 |
| Benazepril | 16 | $243 | $15 |
| Doxazosin Mesylate | 13 | $226 | $17 |
| Pantoprazole | 13 | $140 | $11 |
| Hydrochlorothiazide | 19 | $98 | $5 |
| Atenolol | 15 | $72 | $5 |
2022: 36 drugs
| Eliquis | 234 | $309,434 | $1,322 |
| Entresto | 24 | $28,121 | $1,172 |
| Jardiance | 14 | $25,661 | $1,833 |
| Xarelto | 13 | $20,489 | $1,576 |
| Praluent | 17 | $9,786 | $576 |
| Rosuvastatin | 195 | $7,715 | $40 |
| Metoprolol | 283 | $6,470 | $23 |
| Eplerenone | 23 | $3,581 | $156 |
| Diltiazem 24hr Er (Cd) | 39 | $2,891 | $74 |
| Atorvastatin | 219 | $2,637 | $12 |
| Ezetimibe | 35 | $2,116 | $60 |
| Clopidogrel | 114 | $1,938 | $17 |
| Losartan | 101 | $1,858 | $18 |
| Torsemide | 63 | $1,846 | $29 |
| Valsartan | 43 | $1,598 | $37 |
| Digoxin | 25 | $1,390 | $56 |
| Carvedilol | 93 | $1,361 | $15 |
| Lisinopril | 84 | $997 | $12 |
| Bisoprolol | 17 | $997 | $59 |
| Spironolactone | 82 | $980 | $12 |
| Flecainide Acetate | 13 | $876 | $67 |
| Amlodipine Besylate | 146 | $852 | $6 |
| Isosorbide Mononitrate Er | 26 | $774 | $30 |
| Metoprolol | 58 | $690 | $12 |
| Enalapril Maleate | 17 | $621 | $37 |
| Potassium Chloride | 11 | $606 | $55 |
| Chlorthalidone | 18 | $567 | $32 |
| Furosemide | 76 | $522 | $7 |
| Verapamil Er | 14 | $415 | $30 |
| Simvastatin | 25 | $348 | $14 |
| Nitroglycerin | 12 | $293 | $24 |
| Benazepril | 17 | $278 | $16 |
| Amiodarone | 18 | $265 | $15 |
| Pravastatin | 14 | $206 | $15 |
| Hydrochlorothiazide | 17 | $181 | $11 |
| Atenolol | 20 | $173 | $9 |
2021: 36 drugs
| Eliquis | 285 | $323,122 | $1,134 |
| Xarelto | 19 | $23,714 | $1,248 |
| Metoprolol | 293 | $8,845 | $30 |
| Rosuvastatin | 152 | $5,704 | $38 |
| Eplerenone | 23 | $4,866 | $212 |
| Atorvastatin | 249 | $3,815 | $15 |
| Valsartan | 48 | $2,807 | $58 |
| Losartan | 109 | $2,245 | $21 |
| Diltiazem 24hr Er (Cd) | 47 | $2,209 | $47 |
| Digoxin | 44 | $2,095 | $48 |
| Clopidogrel | 115 | $1,787 | $16 |
| Flecainide Acetate | 19 | $1,731 | $91 |
| Torsemide | 50 | $1,429 | $29 |
| Isosorbide Dinitrate | 14 | $1,321 | $94 |
| Spironolactone | 111 | $1,278 | $12 |
| Bisoprolol | 15 | $1,271 | $85 |
| Carvedilol | 78 | $1,196 | $15 |
| Lisinopril | 102 | $1,143 | $11 |
| Ezetimibe | 17 | $1,108 | $65 |
| Amlodipine Besylate | 136 | $1,005 | $7 |
| Chlorthalidone | 23 | $834 | $36 |
| Metoprolol | 77 | $758 | $10 |
| Isosorbide Mononitrate Er | 25 | $755 | $30 |
| Verapamil Er | 16 | $675 | $42 |
| Furosemide | 107 | $660 | $6 |
| Diltiazem 24hr Er | 16 | $507 | $32 |
| Amiodarone | 11 | $476 | $43 |
| Enalapril Maleate | 13 | $382 | $29 |
| Benazepril | 22 | $373 | $17 |
| Simvastatin | 30 | $369 | $12 |
| Tamsulosin | 12 | $328 | $27 |
| Pravastatin | 15 | $251 | $17 |
| Nitroglycerin | 14 | $199 | $14 |
| Atenolol | 14 | $171 | $12 |
| Hydrochlorothiazide | 21 | $167 | $8 |
| Clonidine | 15 | $109 | $7 |
2020: 41 drugs
| Eliquis | 249 | $256,419 | $1,030 |
| Xarelto | 23 | $26,753 | $1,163 |
| Entresto | 13 | $12,507 | $962 |
| Metoprolol | 331 | $11,692 | $35 |
| Rosuvastatin | 111 | $8,172 | $74 |
| Atorvastatin | 297 | $5,252 | $18 |
| Digoxin | 59 | $2,742 | $46 |
| Clopidogrel | 173 | $2,574 | $15 |
| Diltiazem 24hr Er (Cd) | 34 | $2,481 | $73 |
| Valsartan | 38 | $2,395 | $63 |
| Losartan | 105 | $1,985 | $19 |
| Flecainide Acetate | 16 | $1,715 | $107 |
| Chlorthalidone | 25 | $1,306 | $52 |
| Isosorbide Mononitrate Er | 38 | $1,233 | $32 |
| Carvedilol | 96 | $1,212 | $13 |
| Ezetimibe | 15 | $1,205 | $80 |
| Torsemide | 54 | $1,186 | $22 |
| Spironolactone | 89 | $1,181 | $13 |
| Verapamil Er | 25 | $1,110 | $44 |
| Lisinopril | 93 | $1,063 | $11 |
| Amlodipine Besylate | 144 | $1,011 | $7 |
| Metoprolol | 93 | $945 | $10 |
| Bisoprolol | 14 | $892 | $64 |
| Irbesartan | 11 | $836 | $76 |
| Potassium Chloride | 13 | $759 | $58 |
| Furosemide | 116 | $758 | $7 |
| Enalapril Maleate | 18 | $612 | $34 |
| Doxazosin Mesylate | 13 | $572 | $44 |
| Diltiazem 24hr Er | 17 | $546 | $32 |
| Hydralazine | 17 | $476 | $28 |
| Simvastatin | 41 | $394 | $10 |
| Amiodarone | 18 | $363 | $20 |
| Tamsulosin | 14 | $334 | $24 |
| Nitroglycerin | 20 | $330 | $16 |
| Benazepril | 19 | $311 | $16 |
| Hydrochlorothiazide | 33 | $290 | $9 |
| Warfarin | 11 | $256 | $23 |
| Pravastatin | 13 | $209 | $16 |
| Clonidine | 17 | $152 | $9 |
| Metformin | 13 | $129 | $10 |
| Atenolol | 13 | $98 | $8 |
2019: 41 drugs
| Eliquis | 255 | $207,426 | $813 |
| Xarelto | 19 | $22,674 | $1,193 |
| Metoprolol | 359 | $14,205 | $40 |
| Atorvastatin | 332 | $6,750 | $20 |
| Entresto | 11 | $6,676 | $607 |
| Rosuvastatin | 88 | $6,322 | $72 |
| Eplerenone | 11 | $3,631 | $330 |
| Digoxin | 66 | $3,464 | $52 |
| Diltiazem 24hr Er (Cd) | 49 | $2,571 | $52 |
| Clopidogrel | 126 | $2,203 | $17 |
| Flecainide Acetate | 23 | $1,920 | $83 |
| Chlorthalidone | 27 | $1,561 | $58 |
| Losartan | 108 | $1,542 | $14 |
| Lisinopril | 121 | $1,389 | $11 |
| Spironolactone | 90 | $1,297 | $14 |
| Carvedilol | 77 | $1,290 | $17 |
| Valsartan | 29 | $1,281 | $44 |
| Amlodipine Besylate | 126 | $1,175 | $9 |
| Potassium Chloride | 25 | $1,073 | $43 |
| Ezetimibe | 15 | $1,015 | $68 |
| Metoprolol | 115 | $991 | $9 |
| Enalapril Maleate | 17 | $926 | $54 |
| Bisoprolol | 15 | $912 | $61 |
| Torsemide | 36 | $779 | $22 |
| Simvastatin | 56 | $778 | $14 |
| Isosorbide Mononitrate Er | 32 | $682 | $21 |
| Hydralazine | 12 | $678 | $57 |
| Furosemide | 95 | $629 | $7 |
| Irbesartan | 12 | $563 | $47 |
| Verapamil Er | 13 | $555 | $43 |
| Warfarin | 17 | $513 | $30 |
| Amiodarone | 24 | $454 | $19 |
| Nitroglycerin | 27 | $396 | $15 |
| Tamsulosin | 11 | $360 | $33 |
| Atenolol | 23 | $302 | $13 |
| Hydrochlorothiazide | 30 | $291 | $10 |
| Verapamil | 11 | $253 | $23 |
| Pravastatin | 15 | $244 | $16 |
| Benazepril | 15 | $219 | $15 |
| Metformin | 13 | $165 | $13 |
| Pantoprazole | 12 | $157 | $13 |
2018: 41 drugs
| Eliquis | 225 | $164,322 | $730 |
| Xarelto | 30 | $26,559 | $885 |
| Metoprolol | 412 | $15,144 | $37 |
| Rosuvastatin | 113 | $8,211 | $73 |
| Atorvastatin | 389 | $7,950 | $20 |
| Diltiazem 24hr Er (Cd) | 64 | $6,257 | $98 |
| Eplerenone | 16 | $4,971 | $311 |
| Digoxin | 96 | $4,451 | $46 |
| Brilinta | 12 | $4,236 | $353 |
| Valsartan | 91 | $3,780 | $42 |
| Ezetimibe | 13 | $3,767 | $290 |
| Clopidogrel | 154 | $2,637 | $17 |
| Chlorthalidone | 46 | $2,626 | $57 |
| Flecainide Acetate | 46 | $2,576 | $56 |
| Amiodarone | 31 | $1,708 | $55 |
| Metoprolol | 180 | $1,526 | $8 |
| Lisinopril | 146 | $1,491 | $10 |
| Spironolactone | 94 | $1,323 | $14 |
| Losartan | 128 | $1,274 | $10 |
| Potassium Chloride | 28 | $1,206 | $43 |
| Amlodipine Besylate | 138 | $1,173 | $8 |
| Simvastatin | 106 | $1,154 | $11 |
| Carvedilol | 94 | $1,110 | $12 |
| Sotalol Af | 11 | $1,020 | $93 |
| Isosorbide Mononitrate Er | 36 | $787 | $22 |
| Digox | 12 | $786 | $66 |
| Enalapril Maleate | 14 | $786 | $56 |
| Warfarin | 25 | $727 | $29 |
| Verapamil Er | 11 | $715 | $65 |
| Torsemide | 33 | $637 | $19 |
| Tamsulosin | 18 | $530 | $29 |
| Nitroglycerin | 29 | $529 | $18 |
| Furosemide | 86 | $323 | $4 |
| Atenolol | 28 | $298 | $11 |
| Valsartan-Hydrochlorothiazide | 13 | $297 | $23 |
| Losartan-Hydrochlorothiazide | 13 | $274 | $21 |
| Pantoprazole | 14 | $260 | $19 |
| Pravastatin | 20 | $255 | $13 |
| Metformin | 13 | $181 | $14 |
| Benazepril | 25 | $167 | $7 |
| Hydrochlorothiazide | 18 | $155 | $9 |
2017: 41 drugs
| Eliquis | 235 | $124,473 | $530 |
| Xarelto | 35 | $23,386 | $668 |
| Metoprolol | 364 | $13,011 | $36 |
| Crestor | 20 | $8,170 | $408 |
| Atorvastatin | 443 | $7,755 | $18 |
| Eplerenone | 22 | $5,167 | $235 |
| Rosuvastatin | 54 | $4,835 | $90 |
| Valsartan | 110 | $4,300 | $39 |
| Amiodarone | 65 | $3,935 | $61 |
| Digoxin | 81 | $2,940 | $36 |
| Clopidogrel | 159 | $2,763 | $17 |
| Flecainide Acetate | 55 | $2,500 | $45 |
| Chlorthalidone | 36 | $1,993 | $55 |
| Digox | 21 | $1,779 | $85 |
| Carvedilol | 161 | $1,362 | $8 |
| Potassium Chloride | 24 | $1,303 | $54 |
| Diltiazem 24hr Er | 35 | $1,271 | $36 |
| Metoprolol | 185 | $1,242 | $7 |
| Verapamil Er | 13 | $1,144 | $88 |
| Lisinopril | 141 | $1,104 | $8 |
| Simvastatin | 105 | $1,081 | $10 |
| Enalapril Maleate | 27 | $929 | $34 |
| Losartan | 82 | $908 | $11 |
| Spironolactone | 83 | $878 | $11 |
| Warfarin | 31 | $873 | $28 |
| Isosorbide Mononitrate Er | 39 | $834 | $21 |
| Amlodipine Besylate | 133 | $808 | $6 |
| Tamsulosin | 32 | $669 | $21 |
| Pravastatin | 26 | $627 | $24 |
| Nitroglycerin | 35 | $619 | $18 |
| Bisoprolol | 17 | $487 | $29 |
| Atenolol | 60 | $430 | $7 |
| Hydralazine | 11 | $411 | $37 |
| Torsemide | 14 | $335 | $24 |
| Pantoprazole | 27 | $334 | $12 |
| Furosemide | 84 | $312 | $4 |
| Propafenone | 12 | $239 | $20 |
| Benazepril | 35 | $219 | $6 |
| Valsartan-Hydrochlorothiazide | 14 | $157 | $11 |
| Fosinopril | 13 | $107 | $8 |
| Hydrochlorothiazide | 11 | $37 | $3 |
2016: 43 drugs
| Eliquis | 139 | $60,654 | $436 |
| Crestor | 52 | $25,042 | $482 |
| Xarelto | 27 | $14,263 | $528 |
| Metoprolol | 354 | $14,025 | $40 |
| Zetia | 15 | $8,150 | $543 |
| Atorvastatin | 407 | $8,065 | $20 |
| Propafenone Hcl Er | 18 | $7,593 | $422 |
| Valsartan | 89 | $6,807 | $76 |
| Digoxin | 72 | $3,130 | $43 |
| Clopidogrel | 158 | $2,813 | $18 |
| Flecainide Acetate | 61 | $2,079 | $34 |
| Carvedilol | 198 | $1,945 | $10 |
| Amiodarone | 34 | $1,927 | $57 |
| Eplerenone | 12 | $1,923 | $160 |
| Chlorthalidone | 41 | $1,895 | $46 |
| Lisinopril | 156 | $1,770 | $11 |
| Rosuvastatin | 11 | $1,473 | $134 |
| Metoprolol | 198 | $1,357 | $7 |
| Simvastatin | 123 | $1,345 | $11 |
| Diltiazem 24hr Er | 38 | $1,255 | $33 |
| Amlodipine Besylate | 127 | $1,230 | $10 |
| Losartan | 117 | $1,131 | $10 |
| Digox | 13 | $1,087 | $84 |
| Warfarin | 49 | $1,057 | $22 |
| Isosorbide Mononitrate Er | 58 | $1,035 | $18 |
| Potassium Chloride | 24 | $992 | $41 |
| Pravastatin | 41 | $932 | $23 |
| Tamsulosin | 41 | $901 | $22 |
| Spironolactone | 67 | $758 | $11 |
| Nitrostat | 20 | $598 | $30 |
| Verapamil Er | 11 | $576 | $52 |
| Furosemide | 136 | $541 | $4 |
| Torsemide | 23 | $526 | $23 |
| Hydralazine | 28 | $514 | $18 |
| Atenolol | 63 | $465 | $7 |
| Diltiazem 24hr Cd | 12 | $396 | $33 |
| Enalapril Maleate | 19 | $385 | $20 |
| Benazepril | 29 | $278 | $10 |
| Pantoprazole | 21 | $226 | $11 |
| Propafenone | 11 | $219 | $20 |
| Valsartan-Hydrochlorothiazide | 13 | $154 | $12 |
| Hydrochlorothiazide | 17 | $130 | $8 |
| Metformin | 13 | $111 | $9 |
2015: 37 drugs
| Eliquis | 45 | $17,090 | $380 |
| Metoprolol | 396 | $16,651 | $42 |
| Crestor | 39 | $15,021 | $385 |
| Xarelto | 33 | $14,999 | $455 |
| Atorvastatin | 361 | $7,752 | $21 |
| Valsartan | 55 | $5,041 | $92 |
| Digoxin | 66 | $3,450 | $52 |
| Eplerenone | 23 | $3,417 | $149 |
| Clopidogrel | 194 | $2,578 | $13 |
| Flecainide Acetate | 66 | $2,089 | $32 |
| Diltiazem 24hr Cd | 14 | $1,806 | $129 |
| Carvedilol | 166 | $1,738 | $10 |
| Metoprolol | 197 | $1,539 | $8 |
| Lisinopril | 179 | $1,515 | $8 |
| Amiodarone | 55 | $1,447 | $26 |
| Warfarin | 63 | $1,388 | $22 |
| Simvastatin | 136 | $1,313 | $10 |
| Chlorthalidone | 27 | $1,203 | $45 |
| Losartan | 125 | $1,190 | $10 |
| Amlodipine Besylate | 163 | $1,053 | $6 |
| Isosorbide Mononitrate Er | 71 | $1,002 | $14 |
| Diltiazem 24hr Er | 19 | $886 | $47 |
| Furosemide | 166 | $763 | $5 |
| Nitrostat | 35 | $706 | $20 |
| Pravastatin | 20 | $693 | $35 |
| Potassium Chloride | 20 | $605 | $30 |
| Spironolactone | 71 | $576 | $8 |
| Hydralazine | 35 | $575 | $16 |
| Atenolol | 47 | $511 | $11 |
| Cartia Xt | 17 | $502 | $30 |
| Tamsulosin | 16 | $416 | $26 |
| Propafenone | 12 | $284 | $24 |
| Valsartan-Hydrochlorothiazide | 11 | $282 | $26 |
| Enalapril Maleate | 21 | $281 | $13 |
| Losartan-Hydrochlorothiazide | 17 | $177 | $10 |
| Pantoprazole | 17 | $169 | $10 |
| Benazepril | 26 | $131 | $5 |
2014: 42 drugs
| Metoprolol | 381 | $18,278 | $48 |
| Crestor | 52 | $17,318 | $333 |
| Diovan | 32 | $12,491 | $390 |
| Xarelto | 29 | $11,704 | $404 |
| Atorvastatin | 355 | $6,762 | $19 |
| Zetia | 12 | $4,559 | $380 |
| Clopidogrel | 244 | $4,366 | $18 |
| Eplerenone | 30 | $3,876 | $129 |
| Valsartan | 13 | $3,611 | $278 |
| Digoxin | 53 | $2,793 | $53 |
| Carvedilol | 235 | $2,777 | $12 |
| Vytorin | 11 | $2,065 | $188 |
| Losartan | 147 | $2,064 | $14 |
| Simvastatin | 178 | $1,930 | $11 |
| Metoprolol | 235 | $1,918 | $8 |
| Flecainide Acetate | 61 | $1,913 | $31 |
| Diltiazem 24hr Cd | 12 | $1,812 | $151 |
| Digox | 27 | $1,586 | $59 |
| Lisinopril | 178 | $1,456 | $8 |
| Warfarin | 83 | $1,244 | $15 |
| Pravastatin | 32 | $1,187 | $37 |
| Amlodipine Besylate | 126 | $1,040 | $8 |
| Diltiazem 24hr Er | 28 | $1,017 | $36 |
| Isosorbide Mononitrate Er | 64 | $1,005 | $16 |
| Furosemide | 196 | $873 | $4 |
| Irbesartan | 11 | $798 | $73 |
| Spironolactone | 67 | $659 | $10 |
| Chlorthalidone | 32 | $653 | $20 |
| Hydralazine | 31 | $560 | $18 |
| Propafenone | 21 | $560 | $27 |
| Nitrostat | 28 | $461 | $16 |
| Atenolol | 51 | $333 | $7 |
| Losartan-Hydrochlorothiazide | 11 | $272 | $25 |
| Amiodarone | 44 | $249 | $6 |
| Lovastatin | 15 | $238 | $16 |
| Sotalol | 12 | $217 | $18 |
| Enalapril Maleate | 24 | $208 | $9 |
| Benazepril | 23 | $174 | $8 |
| Metformin | 11 | $139 | $13 |
| Pantoprazole | 13 | $96 | $7 |
| Hydrochlorothiazide | 20 | $90 | $4 |
| Allopurinol | 15 | $66 | $4 |
2013: 41 drugs
| Metoprolol | 377 | $16,278 | $43 |
| Diovan | 42 | $14,038 | $334 |
| Crestor | 40 | $11,086 | $277 |
| Atorvastatin | 271 | $9,059 | $33 |
| Clopidogrel | 180 | $7,963 | $44 |
| Flecainide Acetate | 82 | $3,144 | $38 |
| Metoprolol | 246 | $2,778 | $11 |
| Carvedilol | 190 | $2,564 | $13 |
| Simvastatin | 196 | $2,413 | $12 |
| Warfarin | 92 | $2,082 | $23 |
| Losartan | 117 | $1,880 | $16 |
| Lisinopril | 196 | $1,820 | $9 |
| Diltiazem 24hr Er | 31 | $1,151 | $37 |
| Amlodipine Besylate | 104 | $993 | $10 |
| Propafenone | 19 | $821 | $43 |
| Pravastatin | 41 | $763 | $19 |
| Isosorbide Mononitrate Er | 32 | $674 | $21 |
| Spironolactone | 62 | $626 | $10 |
| Amiodarone | 40 | $541 | $14 |
| Furosemide | 109 | $520 | $5 |
| Digox | 62 | $513 | $8 |
| Cartia Xt | 17 | $488 | $29 |
| Digoxin | 30 | $463 | $15 |
| Valsartan-Hydrochlorothiazide | 11 | $460 | $42 |
| Chlorthalidone | 22 | $446 | $20 |
| Losartan-Hydrochlorothiazide | 15 | $431 | $29 |
| Hydralazine | 23 | $374 | $16 |
| Atenolol | 61 | $374 | $6 |
| Potassium Chloride | 16 | $294 | $18 |
| Lisinopril-Hydrochlorothiazide | 16 | $271 | $17 |
| Benazepril | 32 | $226 | $7 |
| Lovastatin | 15 | $225 | $15 |
| Sotalol | 14 | $215 | $15 |
| Nitrostat | 15 | $211 | $14 |
| Famotidine | 11 | $176 | $16 |
| Hydrochlorothiazide | 27 | $152 | $6 |
| Pantoprazole | 13 | $151 | $12 |
| Enalapril Maleate | 15 | $146 | $10 |
| Alprazolam | 18 | $96 | $5 |
| Metformin | 15 | $79 | $5 |
| Zolpidem | 13 | $46 | $4 |
Money from drug and device companies
$33,524 in 2025
| 2025 | 10 | 69 | $27,969 | $33,524 |
| 2024 | 10 | 100 | $41,400 | $52,968 |
| 2023 | 10 | 90 | $26,551 | $37,506 |
| 2022 | 8 | 61 | $26,919 | $32,015 |
| 2021 | 6 | 79 | $29,398 | $34,743 |
| 2020 | 4 | 19 | $15,875 | $16,381 |
| 2019 | 5 | 60 | $18,400 | $24,982 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Corevalve Evolut R | $31,748 | 43 payments
|
| Edwards Lifesciences | Evoque | $681 | 7 payments
|
| Boston Scientific | Watchman Flx | $381 | 7 payments
|
| Abbott Laboratories | Mitraclip | $202 | 4 payments
|
| Recor Medical | Paradise Ultrasound Renal Denervation System | $172 | 1 payment
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $124 | 2 payments
|
See all 69 published payments
| Abbott Laboratories | Meals · 2025-12-11 | Mitraclip | $19 |
| Shockwave Medical | Meals · 2025-12-05 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $98 |
| Stryker | Meals · 2025-12-04 | Artix Mt | $24 |
| Medtronic | Meals · 2025-11-10 | Corevalve Evolut R | $8 |
| Medtronic | Meals · 2025-11-03 | Corevalve Evolut R | $22 |
| Philips North America | Meals · 2025-10-30 | Igt Devices Undivided | $26 |
| Medtronic | Meals · 2025-10-29 | Corevalve Evolut R | $23 |
| Medtronic | Paid to speak or teach · 2025-10-28 | Corevalve Evolut R | $2,835 |
| Medtronic | Meals · 2025-10-28 | Corevalve Evolut R | $133 |
| Medtronic | Meals · 2025-10-28 | Corevalve Evolut R | $29 |
| Boston Scientific | Meals · 2025-10-26 | Watchman Flx | $65 |
| Recor Medical | Meals · 2025-10-26 | Paradise Ultrasound Renal Denervation System | $172 |
| Medtronic | Meals · 2025-10-19 | Corevalve Evolut R | $26 |
| Abiomed | Meals · 2025-10-01 | None | $71 |
| Abbott Laboratories | Meals · 2025-09-09 | Triclip | $24 |
| Medtronic | Meals · 2025-09-05 | Corevalve Evolut R | $8 |
| Medtronic | Meals · 2025-09-04 | Corevalve Evolut R | $43 |
| Medtronic | Meals · 2025-08-19 | Corevalve Evolut R | $7 |
| Medtronic | Meals · 2025-08-15 | Cobalt Dr Mri Surescan | $57 |
| Penumbra | Meals · 2025-08-14 | Penumbra System | $64 |
| Medtronic | Meals · 2025-08-05 | Corevalve Evolut R | $6 |
| Shockwave Medical | Meals · 2025-07-17 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $26 |
| Medtronic | Meals · 2025-06-27 | Apollotm | $17 |
| Medtronic | Meals · 2025-06-27 | Apollotm | $108 |
| Medtronic | Meals · 2025-06-18 | Corevalve Evolut R | $52 |
| Medtronic | Meals · 2025-06-17 | Corevalve Evolut R | $115 |
| Medtronic | Paid to speak or teach · 2025-06-05 | Corevalve Evolut R | $5,906 |
| Edwards Lifesciences | Meals · 2025-06-02 | Sapien 3 Ultra Resilia | $11 |
| Medtronic | Travel · 2025-05-27 | Corevalve Evolut R | $63 |
| Medtronic | Travel · 2025-05-27 | Corevalve Evolut R | $23 |
| Medtronic | Travel · 2025-05-26 | Corevalve Evolut R | $179 |
| Medtronic | Travel · 2025-05-26 | Corevalve Evolut R | $20 |
| Medtronic | Travel · 2025-05-23 | Corevalve Evolut R | $261 |
| Medtronic | Travel · 2025-05-20 | Corevalve Evolut R | $665 |
| Medtronic | Meals · 2025-05-19 | Corevalve Evolut R | $9 |
| Medtronic | Paid to speak or teach · 2025-05-07 | Corevalve Evolut R | $4,200 |
| Medtronic | Meals · 2025-04-30 | Corevalve Evolut R | $2 |
| Medtronic | Paid to speak or teach · 2025-04-24 | Corevalve Evolut R | $6,497 |
| Medtronic | Meals · 2025-04-24 | Corevalve Evolut R | $7 |
| Boston Scientific | Meals · 2025-04-23 | Farapulse | $47 |
| Philips North America | Meals · 2025-04-10 | Igt Devices Systems Undivided | $31 |
| Medtronic | Travel · 2025-04-07 | Corevalve Evolut R | $539 |
| Medtronic | Meals · 2025-04-07 | Corevalve Evolut R | $23 |
| Medtronic | Meals · 2025-04-07 | Corevalve Evolut R | $15 |
| Medtronic | Meals · 2025-04-07 | Corevalve Evolut R | $16 |
| Medtronic | Travel · 2025-04-03 | Corevalve Evolut R | $381 |
| Boston Scientific | Meals · 2025-03-26 | Watchman Flx | $51 |
| Medtronic | Paid to speak or teach · 2025-03-24 | Corevalve Evolut R | $525 |
| Boston Scientific | Meals · 2025-03-20 | Watchman Flx | $84 |
| Medtronic | Travel · 2025-03-20 | Corevalve Evolut R | $114 |
| Medtronic | Travel · 2025-03-20 | Corevalve Evolut R | $347 |
| Medtronic | Meals · 2025-03-17 | Corevalve Evolut R | $10 |
| Boston Scientific | Meals · 2025-03-12 | Watchman Flx | $51 |
| Medtronic | Paid to speak or teach · 2025-03-12 | Corevalve Evolut R | $525 |
| Boston Scientific | Meals · 2025-03-06 | Watchman Flx | $52 |
| Medtronic | Paid to speak or teach · 2025-02-27 | Corevalve Evolut R | $525 |
| Boston Scientific | Meals · 2025-02-26 | Watchman | $31 |
| Abbott Laboratories | Meals · 2025-02-24 | Mitraclip | $22 |
| Abbott Laboratories | Meals · 2025-02-24 | Mitraclip | $137 |
| Edwards Lifesciences | Travel · 2025-02-05 | Evoque | $260 |
| Medtronic | Paid to speak or teach · 2025-02-04 | Corevalve Evolut R | $1,050 |
| Edwards Lifesciences | Travel · 2025-01-23 | Evoque | $168 |
| Medtronic | Paid to speak or teach · 2025-01-14 | Corevalve Evolut R | $5,906 |
| Medtronic | Travel · 2025-01-14 | Corevalve Evolut R | $415 |
| Medtronic | Meals · 2025-01-14 | Corevalve Evolut R | $37 |
| Edwards Lifesciences | Meals · 2025-01-14 | None | $7 |
| Edwards Lifesciences | Meals · 2025-01-14 | None | $34 |
| Edwards Lifesciences | Meals · 2025-01-14 | None | $24 |
| Edwards Lifesciences | Travel · 2025-01-10 | Evoque | $176 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $52,968
| Medtronic | Corevalve Evolut R | $48,890 | 70 payments
|
| Abbott Laboratories | Mitraclip | $2,801 | 10 payments
|
| Edwards Lifesciences | Evoque | $480 | 2 payments
|
| Boston Scientific | Watchman Flx | $224 | 6 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $170 | 4 payments
|
| Penumbra | Indigo System | $165 | 2 payments
|
| Acist Medical Systems | Cvi Systems | $100 | 1 payment
|
| Sirtex Medical | Sir-Spheres Microspheres | $65 | 2 payments
|
| Terumo Medical | Azur Cx Detachable | $44 | 1 payment
|
| Asahi Intecc USA | Peripheral Vascular | $30 | 2 payments
|
2023: $37,506
| Medtronic | Corevalve Evolut R | $35,135 | 61 payments
|
| Abbott Laboratories | Mitraclip | $1,494 | 9 payments
|
| Boston Scientific | Watchman Flx | $437 | 10 payments
|
| Inari Medical | Flowtriever Catheter, S | $163 | 1 payment
|
| HeartFlow | Ffrct | $94 | 1 payment
|
| Penumbra | Penumbra System | $46 | 2 payments
|
| Abiomed | Impella | $46 | 1 payment
|
| Terumo Medical | Glidesheath Slender | $36 | 2 payments
|
| Philips Electronics North America | (9266) Elca | $30 | 2 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $25 | 1 payment
|
2022: $32,015
| Medtronic | Corevalve Evolut R | $27,856 | 39 payments
|
| Abbott Laboratories | Mitraclip | $3,073 | 9 payments
|
| Medical Device Business Services | Carto 3 | $528 | 2 payments
|
| Boston Scientific | Watchman Access System | $437 | 6 payments
|
| Abiomed | Impella | $66 | 2 payments
|
| Biosense Webster | Carto 3 | $46 | 1 payment
|
| CVRx | Barostim Neo System | $5 | 1 payment
|
| Cardiovascular Systems | Diamondback Peripheral | $4 | 1 payment
|
2021: $34,743
| Medtronic | Corevalve Evolut | $32,538 | 61 payments
|
| Abbott Laboratories | Mitraclip System | $1,570 | 7 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $306 | 6 payments
|
| Boston Scientific | Watchman | $250 | 3 payments
|
| Shockwave Medical | Vascular Lithotripsy | $58 | 1 payment
|
| Acist Medical Systems | Cvi Consumables | $20 | 1 payment
|
2020: $16,381
| Medtronic Vascular | Corevalve Evolut | $13,761 | 12 payments
|
| Abbott Laboratories | Tricuspid Valve Repair System | $2,396 | 5 payments
|
| W. L. Gore & Associates | Cardioform Septal Occluder | $193 | 1 payment
|
| Biotronik | None | $31 | 1 payment
|
2019: $24,982
| Medtronic Vascular | Corevalve Evolut | $21,248 | 37 payments
|
| Abbott Laboratories | Mitra Clip System | $3,168 | 12 payments
|
| Edwards Lifesciences | None | $449 | 7 payments
|
| Boston Scientific | Synergy | $91 | 2 payments
|
| Acist Medical Systems | Cvi Consumables | $26 | 2 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| BOSTON SCIENTIFIC CORPORATION · Championaf · 2022 | Their institution | $57,201 |
| Abbott Laboratories · Clinical Trial To Evaluate Cardiovascular Outcomes in Patients Treated With the Tricuspid Valve Repair System Pivotal · 2022 | Their institution | $43,177 |
| Abbott Laboratories · Cardiovascular Outcomes Assessment of the Mitraclip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation · 2019 | Their institution | $37,625 |
| Abbott Laboratories · Clinical Trial To Evaluate Cardiovascular Outcomes in Patients Treated With the Tricuspid Valve Repair System Pivotal · 2020 | Their institution | $37,477 |
| Abbott Laboratories · Clinical Trial To Evaluate Cardiovascular Outcomes in Patients Treated With the Tricuspid Valve Repair System Pivotal · 2021 | Their institution | $36,316 |
| Abbott Laboratories · Clinical Trial To Evaluate Cardiovascular Outcomes in Patients Treated With the Tricuspid Valve Repair System Pivotal (Triluminate) · 2023 | Their institution | $28,095 |
| Abbott Laboratories · Clinical Trial To Evaluate Cardiovascular Outcomes in Patients Treated With the Tricuspid Valve Repair System Pivotal · 2024 | Their institution | $20,802 |
| Boston Scientific Corporation · Champion-Af · 2025 | Their institution | $16,674 |
| Abbott Laboratories · Nct03904147--Triluminate Pivotal Trial · 2025 | Their institution | $12,438 |
| Boston Scientific Corporation · Champion-Af · 2024 | Their institution | $12,401 |
| Abbott Laboratories · Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial · 2019 | Their institution | $10,768 |
| Boston Scientific Corporation · Champion Af · 2023 | Their institution | $9,652 |
| Boston Scientific Corporation · Champion-Af · 2021 | Their institution | $8,269 |
| Abbott Laboratories · Cardiovascular Outcomes Assessment of the Mitraclip Percutaneous Therapy for Heart Failure Patients With Functional Mr (Coapt) Continued Access Study · 2020 | Their institution | $4,750 |
| Abbott Laboratories · Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial · 2020 | Their institution | $3,261 |
| Abbott Laboratories · Ardiovascular Outcomes Assessment of the Mitraclip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (the Coapt Trial) (Coapt) · 2019 | Their institution | $3,200 |
| Boston Scientific Corporation · Simplaafy · 2025 | Their institution | $2,599 |
| Abbott Laboratories · Absorb III Randomized Controlled Trial (Rct) (Absorb-III) · 2020 | Their institution | $2,362 |
| Abbott Laboratories · Amplatzer Amulet Laa Occluder Trial (Amulet Ide) · 2024 | Their institution | $2,175 |
| Boston Scientific Corporation · Evolve Short Dapt · 2019 | Their institution | $1,938 |
| Abbott Laboratories · Amplatzer Amulet Laa Occluder Trial (Amulet Ide) · 2023 | Their institution | $1,242 |
| Abbott Laboratories · Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial · 2021 | Their institution | $1,073 |
| Abbott Laboratories · Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial · 2022 | Their institution | $1,073 |
| Abbott Laboratories · Cardiovascular Outcomes Assessment of the Mitraclip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation · 2020 | Their institution | $850 |
| Abbott Laboratories · Cardiovascular Outcomes Assessment of the Mitraclip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (the Coapt Trial) · 2020 | Their institution | $650 |
| BOSTON SCIENTIFIC CORPORATION · Evolve Short Dapt · 2020 | Their institution | $588 |
| Abbott Laboratories · Trial To Evaluate Treatment With Abbott Transcatheter Clip Repair System in Patients With Moderate Or Greater Tricuspid Regurgitation (Triluminate) · 2020 | Their institution | $450 |
| Abbott Laboratories · Triluminate Pivotal · 2021 | Their institution | $150 |
Professional record
- NPI
- 1477503308
- Licence
- CA A71128California A71128: Current · expires 2028-02-29
- Trained
- Washington University School of Medicine, 1998
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Cardiology (207RC0000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2006-05-11
- NPI last updated
- 2018-04-19
This is when the NPI record was last certified, not a medical board exam.